Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tabula Rasa Ventures is a prominent venture capital firm based in the United States, dedicated to transforming the healthcare landscape through strategic investments. Founded over 15 years ago, the firm has established a strong reputation for financing innovators who prioritize patient access and overall well-being. With a focus on various sectors within healthcare, including drug development, healthcare infrastructure, and technology, Tabula Rasa Ventures aims to support companies from the inception of their ideas through to growth-stage financing.
The firm operates with a clear mission: to enhance patient access and improve health outcomes through its investments. With a portfolio that includes 12 companies, Tabula Rasa Ventures has demonstrated its commitment to fostering innovation in the healthcare sector. The firm is headquartered in the United States, with office locations in major hubs such as San Francisco and New York, allowing it to tap into a diverse range of healthcare innovations across the country.
Tabula Rasa Ventures specializes in investing in the healthcare sector, with a particular emphasis on drug development, healthcare infrastructure, and technology. The firm provides capital ranging from $50,000 to $1 million, catering to a variety of stages including Pre Seed, Seed, Seed Plus, Series A, and Growth Equity. This flexible investment approach allows Tabula Rasa Ventures to support startups at different phases of their development, from early-stage concepts to more established growth-stage companies.
The firm actively seeks out innovators who are committed to enhancing patient access and overall well-being. By focusing on transformative healthcare solutions, Tabula Rasa Ventures aims to back companies that are not only technologically advanced but also aligned with its mission of democratizing healthcare. This includes investments in areas such as digital health, biotechnology, and healthcare services, ensuring a comprehensive approach to improving health outcomes.
Tabula Rasa Ventures boasts a diverse portfolio of 12 companies that exemplify its commitment to healthcare innovation. Notable investments include Olden Labs, which focuses on animal research technology; Big Leap Health, a player in the insurance sector; and Lykos Therapeutics, which is engaged in drug development. Other significant portfolio companies include DeepWell DTx, specializing in therapeutic gaming; The Synthesis Institute, providing essential training services; and Apollo, which develops therapeutic wearables.
Additionally, the firm has invested in Enthea, a health insurance provider; 2A Biosciences, focused on drug development; Natural Medtech, involved in life sciences; Psynautics, working in digital therapeutics; Terran Biosciences, engaged in biotechnology; and Wavepaths, specializing in digital therapeutics. This varied portfolio reflects Tabula Rasa Ventures' strategic focus on enhancing patient access and well-being through innovative healthcare solutions.
To pitch Tabula Rasa Ventures, please email them at contact@tabularasa.ventures. They welcome pitches that clearly outline your business model and how it aligns with their focus on healthcare innovation.
Tabula Rasa Ventures invests across multiple stages, including Pre Seed, Seed, Seed Plus, Series A, and Growth Equity. This broad range allows them to support startups at various points in their development journey.
Founders can pitch Tabula Rasa Ventures by reaching out via email at contact@tabularasa.ventures. It is advisable to provide a clear overview of the business model, market opportunity, and how the venture aligns with their focus on healthcare innovation.
The firm primarily focuses on the healthcare sector, investing in areas such as drug development, healthcare infrastructure, and technology. They are particularly interested in companies that enhance patient access and overall well-being.
Tabula Rasa Ventures typically invests between $50,000 and $1 million in their portfolio companies, allowing for flexibility in supporting startups at different stages of growth.
Tabula Rasa Ventures is based in the United States and primarily focuses its investments within the country, leveraging its presence in key markets such as San Francisco and New York.
While specific details on portfolio support are not provided, Tabula Rasa Ventures emphasizes a commitment to enhancing patient access and well-being, suggesting they may offer strategic guidance and resources to their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.